Dwayne C. Jones

Array ( [id] => 6307781 [patent_doc_number] => 20020094947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'METHOD OF SIMULTANEOUSLY ENHANCING ANALGESIC POTENCY AND ATTENUATING DEPENDENCE LIABILITY CAUSED BY MORPHINE AND OTHER BIMODALLY-ACTING OPIOID AGONISTS' [patent_app_type] => new [patent_app_number] => 10/037791 [patent_app_country] => US [patent_app_date] => 2002-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7617 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094947.pdf [firstpage_image] =>[orig_patent_app_number] => 10037791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575155 [patent_doc_number] => 06468997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-22 [patent_title] => 'Desmethylolanzapine compositions and methods' [patent_app_type] => B2 [patent_app_number] => 10/026303 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3162 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468997.pdf [firstpage_image] =>[orig_patent_app_number] => 10026303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935448 [patent_doc_number] => 20020061311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Methods and compositions for inducing oral tolerance in mammals' [patent_app_type] => new [patent_app_number] => 10/017076 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8064 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061311.pdf [firstpage_image] =>[orig_patent_app_number] => 10017076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936724 [patent_doc_number] => 20020061910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Method of treating or preventing chronic pain' [patent_app_type] => new [patent_app_number] => 10/020261 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9163 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061910.pdf [firstpage_image] =>[orig_patent_app_number] => 10020261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5846373 [patent_doc_number] => 20020133047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Isomeric nonanols and decanols, their preparation, phthalic esters obtained therefrom, and their use as plasticizers' [patent_app_type] => new [patent_app_number] => 10/020007 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3348 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133047.pdf [firstpage_image] =>[orig_patent_app_number] => 10020007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467458 [patent_doc_number] => 06458845 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Macrophage scavenger receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 10/018457 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4308 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458845.pdf [firstpage_image] =>[orig_patent_app_number] => 10018457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651823 [patent_doc_number] => 20030105104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy' [patent_app_type] => new [patent_app_number] => 09/995010 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6374 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105104.pdf [firstpage_image] =>[orig_patent_app_number] => 09995010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082745 [patent_doc_number] => 20020082304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Denaturants for sympathomimetic amine salts' [patent_app_type] => new [patent_app_number] => 09/996438 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7797 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082304.pdf [firstpage_image] =>[orig_patent_app_number] => 09996438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000633 [patent_doc_number] => 20020028802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Process for the isolation of galanthamine' [patent_app_type] => new [patent_app_number] => 09/986792 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1840 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028802.pdf [firstpage_image] =>[orig_patent_app_number] => 09986792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961147 [patent_doc_number] => 06951860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 09/998623 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14537 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 394 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951860.pdf [firstpage_image] =>[orig_patent_app_number] => 09998623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706801 [patent_doc_number] => 20030153535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Primary N-hydroxylamines' [patent_app_type] => new [patent_app_number] => 10/038135 [patent_app_country] => US [patent_app_date] => 2001-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18932 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153535.pdf [firstpage_image] =>[orig_patent_app_number] => 10038135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046892 [patent_doc_number] => 06864288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-08 [patent_title] => 'Regulation of phospholipase D activity' [patent_app_type] => utility [patent_app_number] => 10/004155 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15292 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864288.pdf [firstpage_image] =>[orig_patent_app_number] => 10004155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982394 [patent_doc_number] => 06927238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Regulation of phospholipase D activity' [patent_app_type] => utility [patent_app_number] => 10/042043 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15287 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 542 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927238.pdf [firstpage_image] =>[orig_patent_app_number] => 10042043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1399671 [patent_doc_number] => 06531511 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => '2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission' [patent_app_type] => B1 [patent_app_number] => 09/890061 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8724 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531511.pdf [firstpage_image] =>[orig_patent_app_number] => 09890061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316091 [patent_doc_number] => 06608050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-19 [patent_title] => 'Lyophilizate of lipid complex of water insoluble porphyrins' [patent_app_type] => B2 [patent_app_number] => 09/970596 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4063 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608050.pdf [firstpage_image] =>[orig_patent_app_number] => 09970596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783574 [patent_doc_number] => 20030065022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Injectable composition' [patent_app_type] => new [patent_app_number] => 09/970558 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1228 [patent_no_of_claims] => 304 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065022.pdf [firstpage_image] =>[orig_patent_app_number] => 09970558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802292 [patent_doc_number] => 20020010201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Method for treating restless leg syndrome using pramipexole and clonidine' [patent_app_type] => new [patent_app_number] => 09/970839 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2583 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010201.pdf [firstpage_image] =>[orig_patent_app_number] => 09970839 [rel_patent_id] =>[rel_patent_doc_number] =>)